Design and evaluation of multi-target AGEs/ALEs inhibitors for potential application in skin anti-aging

N Andre Sasaki1, Pascal Sonnet1

  • 1AGIR, UR4294, UFR of Pharmacy, Jules Verne University of Picardie, Amiens, France.

Insights

New multi-targeted compounds neutralize reactive oxygen species (ROS) and reactive carbonyl species (RCS), offering potent anti-aging effects for skin. These novel compounds effectively combat skin aging factors like oxidative stress and collagen damage.

Area of Science:

  • Dermatology and Cosmetic Science
  • Biochemistry
  • Materials Science

Background:

  • Skin aging results from intrinsic and extrinsic factors, including oxidative stress from reactive oxygen species (ROS) and collagen modification by reactive carbonyl species (RCS).
  • While numerous compounds like Vitamin C and retinoids are used in anti-aging products, there's a need for multi-targeted solutions.
  • Delaying visible skin aging is a significant goal for many individuals, particularly older adults.

Purpose of the Study:

  • To introduce and characterize novel multi-targeted anti-aging compounds for skin applications.
  • To evaluate the efficacy of these compounds in neutralizing key aging factors (ROS and RCS).

Main Methods:

  • Development of compounds with dual functional moieties: one for ROS neutralization and one for RCS scavenging.
  • Assessment of antioxidant capacity using ORAC (Oxygen Radical Absorbance Capacity) assay, comparing to Trolox.
  • Evaluation of transition-metal-chelating activity.

Main Results:

  • The new compounds demonstrated rapid and efficient scavenging of RCS.
  • Achieved an ORAC value more than double that of Trolox, indicating potent antioxidant activity.
  • Exhibited strong transition-metal-chelating activity, further contributing to anti-aging properties.

Conclusions:

  • The developed multi-targeted compounds show significant potential for combating skin aging.
  • Their dual action against ROS and RCS, coupled with high antioxidant and chelating activities, makes them promising for advanced skincare formulations.

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...